DNMT1 and breast carcinoma: However, in breast cancer cell lines, this combination suppressed cell proliferation by increasing the mRNA and protein levels of Brca1 due to decreased promoter methylation, the downregulation of both DNMT1 expression and miR-29b, and the upregulation of TET1 and DNMT3.